Traditional Chinese medicine for treatment of cerebral hemorrhage

Abstract

The invention relates to traditional Chinese medicine for treatment of cerebral hemorrhage. The traditional Chinese medicine comprises the following components in parts by weight: 50 parts of astragali radix, 30 parts of lumbricus, 30 parts of loofah sponge, 20 parts of ramulus mori, 20 parts of Chinese angelica, 25 parts of ligusticum wallichii, 30 parts of radix paeoniae rubra, 15 parts of radix bupleuri, 20 parts of oriental wormwood, 30 parts of peach kernel, 20 parts of safflower carthamus, 15 parts of radix angelicae, 15 parts of rhizoma cyperi, 20 parts of frankincense, 20 parts of myrrh and 10 parts of Chinese date. The traditional Chinese medicine for treatment of cerebral hemorrhage has no toxic Chinese herbal medicinal ingredients, has no toxic side effects, is low in cost, and can be used for treatment of various cerebral hemorrhage with the course of treatment for about 20 to 30 days, the curative effect is good, the effective rate reaches 100%, and the cure rate is more than 90%.

Description

technical field [0001] The invention relates to a traditional Chinese medicine for treating cerebral hemorrhage. Background technique [0002] With the improvement of people's living standards, the acceleration of the pace of life, and the increase in psychological pressure, there are more and more patients with cerebral hemorrhage. Cerebral hemorrhage is an important factor that endangers people's health, especially the health of middle-aged and elderly people. The disease tends to be younger, and the disease often has a sudden onset and rapid progression. Among cerebrovascular diseases, its mortality rate ranks first. After cerebral hemorrhage, surgical treatment is generally adopted for patients with serious conditions, and conservative drug treatment is used for mild conditions. There is no early application of traditional Chinese medicine. Mental burden, the treatment of traditional Chinese medicine is often applied in the recovery period of the patient, and cannot re...

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to solve the shortcoming that Chinese medicine cannot be used in the acute stage of patients with cerebral hemorrhage. No matter whether the patient adopts surgery or conservative treatment after three days of cerebral hemorrhage, the Chinese medicine should be used before the sequelae are formed, and early intervention is performed to eliminate or reduce the occurrence of sequelae.